Detalhe da pesquisa
1.
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 21(8): 1405-1412, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25840338
2.
Incidence and Outcomes of Cytomegalovirus Reactivation after Chimeric Antigen Receptor T Cell Therapy.
Blood Adv
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38838226
3.
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
Bone Marrow Transplant
; 56(12): 3068-3077, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584240
4.
Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT).
Leuk Lymphoma
; 61(4): 940-943, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31793821
5.
Hereditary inflammatory breast cancer associated with BRCA2 mutation: a rare disease presentation in mother and daughter.
Clin Adv Hematol Oncol
; 10(6): 402-4, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895246
6.
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
Bone Marrow Transplant
; 57(5): 852, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297406
7.
Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.
Front Immunol
; 6: 36, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25699052